128 related articles for article (PubMed ID: 16494006)
21. [Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray].
Wang XY; Liu T; Zhu CZ; Li Y; Sun R; Sun CY; Wang AX
Ai Zheng; 2005 Sep; 24(9):1091-5. PubMed ID: 16159431
[TBL] [Abstract][Full Text] [Related]
22. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer.
Zhou L; Yu L; Wu S; Feng Z; Song W; Gong X
World J Surg Oncol; 2015 Aug; 13():234. PubMed ID: 26231404
[TBL] [Abstract][Full Text] [Related]
24. KAI1/CD82 expression in nonsmall cell lung carcinoma is a novel, favorable prognostic factor: an immunohistochemical analysis.
Higashiyama M; Kodama K; Yokouchi H; Takami K; Adachi M; Taki T; Ishiguro S; Nakamori S; Yoshie O; Miyake M
Cancer; 1998 Aug; 83(3):466-74. PubMed ID: 9690539
[TBL] [Abstract][Full Text] [Related]
25. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
26. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
[TBL] [Abstract][Full Text] [Related]
27. KAI1/CD82 expression as a prognosic factor in sporadic colorectal cancer.
Muneyuki T; Watanabe M; Yamanaka M; Shiraishi T; Isaji S
Anticancer Res; 2001; 21(5):3581-7. PubMed ID: 11848527
[TBL] [Abstract][Full Text] [Related]
28. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
[TBL] [Abstract][Full Text] [Related]
29. Expression of metastasis suppressor gene (KAI1/CD82) in oral squamous cell carcinoma and its clinico-pathological significance.
Imai Y; Sasaki T; Shinagawa Y; Akimoto K; Fujibayashi T
Oral Oncol; 2002 Sep; 38(6):557-61. PubMed ID: 12167433
[TBL] [Abstract][Full Text] [Related]
30. [Expression of androgen receptor and estrogen receptor in carcinoma of larynx].
Chen B; Wang J; Li W; Ji W
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Jul; 20(14):649-51. PubMed ID: 17017191
[TBL] [Abstract][Full Text] [Related]
31. Clinical significance of KAI1/CD82 protein expression in nasopharyngeal carcinoma.
Wang G; Jiang H; Xu H; Sun Q; Zhou Y; Xiang P; Cheng Z; Zhang Y; Zhou Y; Guo Q; DU X; Xu S; Ma S; Chen Z
Oncol Lett; 2015 Apr; 9(4):1681-1686. PubMed ID: 25789023
[TBL] [Abstract][Full Text] [Related]
32. High prevalence of decreased expression of KAI1 metastasis suppressor in human oral carcinogenesis.
Uzawa K; Ono K; Suzuki H; Tanaka C; Yakushiji T; Yamamoto N; Yokoe H; Tanzawa H
Clin Cancer Res; 2002 Mar; 8(3):828-35. PubMed ID: 11895916
[TBL] [Abstract][Full Text] [Related]
33. [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential].
Li S; Fang W; Zhong H
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):708-10. PubMed ID: 11715465
[TBL] [Abstract][Full Text] [Related]
34. Expression and clinical significance of p53, JunB and KAI1/CD82 in human hepatocellular carcinoma.
Guo C; Liu QG; Zhang L; Song T; Yang X
Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):389-96. PubMed ID: 19666408
[TBL] [Abstract][Full Text] [Related]
35. Loss of KAI1/CD82 expression in bone and soft tissue tumors is not associated with lung metastasis.
Arihiro K; Inai K
Pathol Res Pract; 2001; 197(9):627-33. PubMed ID: 11569927
[TBL] [Abstract][Full Text] [Related]
36. [The expression and significance of SDF-1/CXCR4 biological axis in laryngeal squamous cell carcinoma and lymph node metastasize].
Zhang L; Xiong C; Wu Y; Shi H; Jing S; Song J; Zhao Z; Shan B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Sep; 26(18):798-801. PubMed ID: 23259294
[TBL] [Abstract][Full Text] [Related]
37. Novel staging protocol for non-small-cell lung cancers according to MRP-1/CD9 and KAI1/CD82 gene expression.
Adachi M; Taki T; Konishi T; Huang CI; Higashiyama M; Miyake M
J Clin Oncol; 1998 Apr; 16(4):1397-406. PubMed ID: 9552043
[TBL] [Abstract][Full Text] [Related]
38. Correlation of KAI1/CD82 gene expression with good prognosis in patients with non-small cell lung cancer.
Adachi M; Taki T; Ieki Y; Huang CL; Higashiyama M; Miyake M
Cancer Res; 1996 Apr; 56(8):1751-5. PubMed ID: 8620488
[TBL] [Abstract][Full Text] [Related]
39. [Expression of nm23 and KAI1 and their clinical significance in gallbladder adenocarcinoma].
Jiang WX; Song BG; Tang RY; Fang JP
Zhonghua Zhong Liu Za Zhi; 2008 Jun; 30(6):441-3. PubMed ID: 19024519
[TBL] [Abstract][Full Text] [Related]
40. KAI1/CD82 suppresses hepatocyte growth factor-induced migration of hepatoma cells via upregulation of Sprouty2.
Mu Z; Wang H; Zhang J; Li Q; Wang L; Guo X
Sci China C Life Sci; 2008 Jul; 51(7):648-54. PubMed ID: 18622748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
